BioDelivery Sciences International
Financial ratios & Valuation

Historical Multiples (2012 – 2021)

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
80.42-3.89-10.72-6.66-1.3930.89-6.90-34.3616.303.776.50-1.39
Price/Sales ratio
2.4319.6714.925.206.042.634.204.722.671.926.556.04
Price/Book Value ratio
2.66-275.0910.687.91-5.3118.397.857.533.871.702.93-5.31
Price/Cash Flow ratio
10.90-3.71-20.15-67.23-1.74-5.03-9.6947.4916.787.8020.21-1.74
Price/Free Cash Flow ratio
11.97-3.71-19.09-56.60-1.72-4.26-8.9247.8416.797.8820.53-1.72
Price/Earnings Growth ratio
0.750.000.410.18-0.01-0.280.010.51-0.060.010.03-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
96.49%81.66%87.31%83.20%27.58%68.54%71.63%80.61%84.23%85.97%72.23%27.58%
Operating Profit Margin
12.94%-496.67%-99.47%-72.93%-411.26%-47.46%-42.50%3.35%21.07%22.26%44.10%-411.26%
Pretax Profit Margin
3.26%-505.40%-139.22%-78.10%-431.86%-17.24%-60.84%-13.73%16.59%17.76%35.19%-431.86%
Net Profit Margin
3.02%-505.40%-139.22%-78.10%-431.86%8.52%-60.86%-13.74%16.43%50.90%100.81%-431.86%
Effective Tax Rate
7.24%0.15%24.82%-0.06%-0.09%149.45%-0.03%-0.03%0.97%-186.47%-186.47%149.45%
Return on Assets
2.18%-151.01%-60.70%-36.65%-128.31%5.99%-31.20%-8.36%10.71%26.14%26.14%-128.31%
Return On Equity
3.31%7065.12%-99.67%-118.85%380.06%59.53%-113.86%-21.93%23.75%45.18%63.64%63.64%
Return on Capital Employed
13.45%-433.39%-64.44%-47.10%-197.13%-47.48%-27.18%2.89%17.64%15.32%15.32%-197.13%
Liquidity Ratios
Current Ratio
2.751.062.683.292.161.523.062.183.44N/A2.362.16
Quick Ratio
2.741.032.613.201.991.282.811.973.112.162.071.99
Cash ratio
2.710.922.412.971.600.812.031.182.101.381.381.38
Days of Sales Outstanding
3.4889.8029.4318.8283.7952.1289.39127.10112.31124.51246.5983.79
Days of Inventory outstanding
N/AN/A135.09115.25109.19114.03125.01191.24258.12370.27370.27109.19
Operating Cycle
3.4889.80164.53134.08192.99166.15214.41318.34370.44494.78431.08192.99
Days of Payables Outstanding
N/AN/A670.43458.53304.66229.0773.21197.8662.34126.71N/A229.07
Cash Conversion Cycle
3.4889.80-505.90-324.45-111.67-62.92141.19120.48308.10368.07337.89-111.67
Debt Ratios
Debt Ratio
0.340.500.130.280.550.540.470.320.320.180.420.54
Debt Equity Ratio
0.52-23.600.220.91-1.655.361.730.830.720.310.72-1.65
Long-term Debt to Capitalization
N/A1.070.070.412.520.840.630.450.420.22N/A0.84
Total Debt to Capitalization
N/A1.040.180.472.520.840.630.450.420.23N/A0.84
Interest Coverage Ratio
-25.15-62.48-19.21-13.97-19.56-3.43-2.320.194.70N/A-4.95-19.56
Cash Flow to Debt Ratio
N/A-3.13-2.36-0.12-1.84-0.68-0.460.180.310.69N/A-1.84
Company Equity Multiplier
1.52-46.781.643.24-2.969.923.642.622.211.721.72-2.96
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.22-5.29-0.74-0.07-3.47-0.52-0.430.090.150.240.32-3.47
Free Cash Flow / Operating Cash Flow Ratio
0.911.001.051.181.001.181.080.990.990.980.981.18
Cash Flow Coverage Ratio
N/A-3.13-2.36-0.12-1.84-0.68-0.460.180.310.69N/A-1.84
Short Term Coverage Ratio
N/A-8.19-3.60-0.55N/AN/AN/AN/AN/A8.895.91N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A